FIELD: medicine. SUBSTANCE: method involves applying instrumental and clinical examination of patient based on administered preparations belonging to phthalhydrazide group. EFFECT: enhanced effectiveness in detecting and diagnosing oncological diseases. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF IMMUNE SYSTEM CORRECTION | 1995 |
|
RU2108806C1 |
| MEDICINAL PREPARATION AND METHOD OF ITS PREPARING | 2001 |
|
RU2193883C1 |
| MEDICINAL AGENT | 2000 |
|
RU2163122C1 |
| METHOD FOR PROTECTION AGAINST CORONAVIRUS INFECTION | 2020 |
|
RU2747467C1 |
| MEDICINAL PREPARATION | 2003 |
|
RU2238730C1 |
| PHARMACEUTICAL COMPOSITION WITH IMMUNOMODULATORY, IMMUNOCORRECTING, IMMUNOSUPPRESSIVE, ANTIVIRAL, ANTI-INFLAMMATORY AND ONCOLYTIC ACTIVITIES | 2021 |
|
RU2775008C1 |
| VACCINE AND METHOD FOR INCREASING IMMUNOGENICITY AND SPECIFIC ACTIVITY OF INFECTION PREVENTION AGENTS | 2020 |
|
RU2741834C1 |
| METHOD OF TREATMENT OF PATIENTS WITH RICKETTSIOSIS | 2000 |
|
RU2171676C1 |
| DRUGS HAVING IMMUNOMODULATORY, ANTI-INFLAMMATORY AND ANTI-TUMOR PROPERTIES AND METHOD FOR PRODUCTION THEREOF | 2004 |
|
RU2295335C2 |
| DRUGS HAVING IMMUNOMODULATORY, ANTI-INFLAMMATORY AND ANTI-TUMOR PROPERTIES AND METHOD FOR PRODUCTION THEREOF | 2004 |
|
RU2295338C2 |
